Release time:2022-05-31

As an industry-leading innovative R & D driven Pharmaceutical Group, Sino biopharmaceutical adheres to the quality policy of "taking product quality as the foundation of the enterprise's life and customer satisfaction as the enterprise's unremitting pursuit", sets up a quality management system with the board of directors as the highest responsible organization, integrates quality assurance into the whole life cycle management of products, and realizes the circular quality management of planning, execution, inspection and treatment, organized, planned Continuous quality improvement.



Sino biopharmaceuticals, based on the contents of the Pharmacopoeia of the people's Republic of China, European Pharmacopoeia (EP), United States Pharmacopoeia (USP) and other internal and external Pharmacopoeia of China, the operational standard of solubility inspection method, high performance liquid chromatography (HPLC) operational standard of heavy metal inspection method, asepsis operational standard, etc. a series of detection methods, detection items including characterization Dissolution (solid preparation) and clarity (injection), etc. the types of tests cover the purpose, physicochemical and microbiological tests, etc. In 2021, Sino biopharmaceuticals performed a full inspection of each batch of products in accordance with legal standards to ensure the quality of the products meets the requirements.